Sign In to Follow Application
View All Documents & Correspondence

Foaming Skin Cleansing Composition Containing Free Fatty Acids

Abstract: A foaming non-soap based skin cleansing composition comprising0.l to 10% w/w free fatty acids; 2 to 30% w/w surfactants; and water; wherein said free fatty acids are combination of C10 to C20 fatty acids selected from the group comprising Lauric acid, Myristic acid, Palmitic acid, and Stearic acid, and wherein said free fatty acids and surfactants are combined in the ratio of 1:20 to 1:3; such that the destruction of foam by the presence of fatty acids is prevented.Also provided isa process for the preparation of the foaming non-soap skin care composition.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
07 October 2013
Publication Number
15/2015
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2019-09-02
Renewal Date

Applicants

ITC LIMITED
37, J.L. NEHRU ROAD, KOLKATA-700071, WEST BENGAL, INDIA.

Inventors

1. BISWAS, SAMARES, CHANDRA
ITC LIMITED, ITC R&D CENTRE,#3, 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE 1, BENGALURU-560058, INDIA
2. PANIGRAHI, SUDIPA
ITC LIMITED, ITC R&D CENTRE,#3, 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE 1, BENGALURU-560058, INDIA

Specification

Field of the invention
The present invention relates to a skin cleansing composition, more particularly to a
skin cleansing compositionthat incorporates high amounts of Free Fatty Acids (FFA).
Background and prior arts of the invention
Cosmetic treatment involving skin cleansing is gaining much more attention in view
that skin regularly gets exposed to various agents such as UV rays, pollutants, and other
oxidative agents, which in turn act on fatty acid components of skin and makes skin
vulnerable to various dermatological ailments such as cancers, inflammation, allergy
and eczema. Washing skin with detergents such as soaps is widely followed procedure
for cleaning the surface of the skin but during this process the composition of fatty acids
of skin gets altered which leads to harsh feeling and dryness of skin. Accumulating
documented evidences suggest major disadvantages of using soap based cleansing
systems,as they are very harsh and make the skin dry, leaving white residues on skin
surface apart from altering the normal pH of the skin surface.
Prior art reported many skin cleansing soap compositions comprising of different grades
of surfactants such as anionic, cationic, non-ionic, amphoteric etc., used in
combinations. However these formulations have to be considered only after ensuring
their degree of harshness to the skin.
WO2008037609 relates to detergent compositions suitable for topical application for
cleansing and moisturizing the human skin and hair. This prior art identifies the stability
problems associated with cleansers containing combinations of substantial amounts of
hydrophobic emollients for skin conditioning, to produce good foaming and therefore
provides a cleansing composition with a foam, volumes greater than or equal to 20 ml.
This very mild and highly foaming personal cleansing composition further comprises of
0.5 to 20% by wt. of total N-(C6-C20) acyl sarcosinate surfactants; 0.5 to 50% by wt. of
total hydrocarbon or wax emollients or blends; Greater than 0.5% by wt.C10-C18 fatty

acids; 5-95% by wt water, while the ratio of the sarcosinate surfactant to the total
hydrocarbon or wax emollients is in the range of 0.04-2.0. The inventive feature of
WO2008037609 is the specific ratio in which C6-C20 acyl sarcosinates and total
hydrocarbon wax oil emollients are combined to give a liquid crystalline structure that
helps in providing good cleansing feel to the end user.
US 20060018865relates to a foaming cleansing composition which can be rinsed off
with water and has an appearance of gel. This foaming gel composition having both
good cosmetic properties (qualities of the foam and quality of rinsing) and good
properties of tolerance is provided by using surfactant system comprising at least one
alkyl glycol carboxylate and at least one surfactant of the mono/di alkyl phosphates and
their salts.
US5994280relates to foam-producing personal cleansing compositions suitable for
simultaneously cleansing and conditioning the skin and/or the hair and which may be
used, for in the form of foam bath preparations, shower products, skin cleansers, hand,
face and body cleansers, shampoos, etc. This prior art identifies the need for personal
cleansing products with abundant, stable and high quality foam generation capabilities
and at the same time providing the user good moisturizing and good rinsability
characteristics. US '280 teaches a moisturizing personal cleansing composition that
contain a total level of surfactant (inclusive of anionic, amphoteric, nonionic, betaine
and other surfactant components) from about 10% to about 35% by weight of
composition and about 0.1% to about 8% by weight of a fatty acid having an average
chain length of 10 to about 18 carbon atoms. The composition also contains about 1.5%
to about 10% by weight of citric acid or water soluble citrate salt or mixture thereof
along with water.
The above prior art compositions contains free fatty acids but is lesser amount. It is
known that free fatty acids in a soap composition impart higher moisturizing benefit. •
During skin cleansing process the composition of fatty acids of skin gets altered which
leads to harsh feeling and dryness of skin. It is desired to have a mild and /or
moisturizing skin cleansing system. One of the ways for formulating a mild skin

cleansing composition is incorporation of free fatty acid (FFA) in cleansing
formulations. Skin cleansing system having high amount of free fatty acid (FFA) is
highly accepted among the customers. Preparation of Skin cleansing system with high
amount of FFA is well known state of the art, however most of these formulation are
either soap based systems or non -soap based systems. Major disadvantage of using
soap based cleansing system is that it makes the skin dry and leaves white residue on
skin surface and also alters skin surface pH and is very harsh to use. Non-soap based
skin cleansing system has more likeability profile among customers. Foam formation is
one of the essential features of any cleansing system and it is well known state of the art
that FFA inhibitfoam formation and destabilize foam.
Hence it is required to develop a non-soap based foaming skin cleansing composition
incorporating high amount of FFA.
Object of invention
The object of the present invention is to overcome the drawbacks of the prior art.
Another object of the present invention is to provide a foaming skin cleansing
composition comprising high amount of free fatty acids.
Yet another object of the present invention is to provide skin cleansing system with a
unique combination of anionic, non-ionic and amphoteric surfactant that prevents the
destruction of foam by the activity of fatty acids in the composition.
Yet another object of the present invention is to develop a non-soap based skin
cleansing composition with high amount of FFA, which provides high and stable foam
characteristics, which would be highly preferred by the users.
A further object of the present invention is to provide a process for the preparation of
the foaming cleansing composition with high amount of FFA.

Summary of invention;
The present invention provides a foaming non-soap skincleansing composition
comprising
a. 0.1 to 10% w/w free fatty acids;
b. 2 to 30% w/w surfactants; and
c. water;
wherein said free fatty acids are combination of C10 to C20 fatty acids selected
from the group comprising Laurie acid, Myristic acid, Palmitic acid, and Stearic
acid wherein said free fatty acids and surfactants are combined in the ratio of 1:
20 to 1:3.
such that the destruction of foam by the presence of fatty acids is prevented.
The present invention further provides a process for the preparation of a skin care
composition comprises steps of
a. Weighing the surfactants in a container and keeping it aside for continuous
stirring at a temperature ranging from 50-70°C for about 5 to60 minutes. The
continuous stirring process helps in the formation of phase A;
b. Preparing phase B by melting fatty acids in a container kept in water bath at a
temperature ranging from 50 to 80°C for about 5to 60minutes under continuous
stirring;
c. Weighing and mixing polymers and water soluble actives which is helpful for the
preparation of phase C;
d. Adding and mixing phase A and phase C together to form a homogenous
mixture;
e. Adding phase B to the homogenous mixture of step (d) and stirring continuously
to obtain the desired formulation of the present invention.
Detailed description of the invention:

The present inventors have found that the product of the present invention provides
aunique combination of surfactants,free fatty acids and water in such a way that the free
fatty acids does not destroy the foam characteristics the system.
An embodiment of the present invention provides a foaming non-soap based skin
cleansing composition comprising:
a) free fatty acids 0.1-10% by weight,
b) surfactants in the range of about 2 to 30% by weight, and
c) water;
wherein said free fatty acids are combination of C10 to C20 fatty acids selected
from the group comprising Laurie acid,Myristic acid, Palmitic acid, and Stearic acid
wherein said free fatty acids and surfactants are combined in the ratio of 1: 20 to
1:3.
such that the destruction of foam by the presence of fatty acids is prevented.
It has been surprisingly found that the unique combination of surfactant, free fatty acids
and water acts in such a way that the free fatty acids do not destroy the foam of the
system.
For the foaming non-soap based skin cleansing composition of the present invention,
the fatty acids used are Laurie acid,Myristic acid, Palmitic acid, andStearic acid .
The fatty acids are essential for the foaming non-soap based skin cleansing composition
of thepresent invention and also their combination in a particular ratio and range is
important to achieve the desired result. Laurie acid is used in the range of 15 to 35%
w/w,Myristic acid is used in the range of 15 to 30% w/w, Palmitic acid is used in the
range of 15 to 35% w/w, and Stearic acid is used in the range of 15 to 35% w/w
respectively of the total fatty acid mixture.
The surfactant mixture is around 1-20 % w/w in the sample comprises anionic, non
ionic and amphoteric surfactant.

The surfactants can be selected from a group comprising a variety of foam-producing
anionic, cationic and nonionic surfactants.
The anionic surfactants of the composition are present in a range of about 1- 20 wt %,
preferably from 2 to 15%. Suitable anionic surfactants can be selected from a group
comprising but are not limited to anionic surfactants derived from plant-derived
glycerides, more preferably from at least two different sources (e.g. palm oil and
coconut oil). Theglyceride mentioned usually contains about 8 to 24 aliphatic carbon
atoms.
Some of the vegetable oils from which anionic surfactants are derived include, but are
not limited to palm oil, palm kernel oil, olive oil, coconut oil, soybean oil, almond oil,
jojoba oil, and avocado oil. Other anionic surfactants may also be used in place of or in
conjunction with plant-derived or animal-derived anionic surfactants. Some of the
anionic surfactants used include but are not limited to sodium laureth-6 carboxylate,
sodium lauramido diacetate, sodium trideceth-7 carboxylate, sodium stearoyl
lactalbumin, and mixtures thereof. Sulfurcontaininganionic surfactants can be chosen
fromalkoyl isethionates including ammonium cocoyl isethionate, sodium cocoyl
isethionate, sodium lauroyl isethionate, sodium tridecylbenzenesulfonate and mixtures
thereof.
Surfactants derived from amino acid such as glycinate, sulfosuccinate may also be used.
Alternatively, synthetically prepared fatty acids (e.g. by oxidation of petroleum stocks
or by the Fischer-Tropsch process) may be used alone or in combination with the fatty
acid salts of natural origin. Sodium laureth sulfate, or sodium lauryl ether sulfate SLES
nEO, where n may vary from 1 to 7, glutamate such as disodiumcocoyl glutamate,
sulfosuccinate and mixtures thereof are the preferred anionic surfactants.
The amount of non-ionic surfactants present in the product of the present invention
ranges froml- 20wt%, preferably from 2 to 15%. The non-ionic surfactants are selected
from a group comprising condensation products of long chain alcohols with sugar or
starch polymers (e.g. decyl polyglucoside and lauryl polyglucoside), amides (e.g.

cocoamide diethanolamine and cocoamide monoethanolamine), alkylene oxide derived
surfactants (e.g. ceteth-6, ceteareth6, steareth-6, PEG-12 stearate, and PEG-200 glyceryl
tallowate), ethoxylated and/or propoxylated (C5-C12 alkyl)phenols ethers containing 5
to 20 EO or PO units (such as polyethylene glycol nonylphenyl ethers, polyethylene
glycol octylphenyl ethers, also known under the generic tradename Polystep®),
polyethylene glycol sorbitol ether containing 3 to 30 EO (ethylene oxide) units (such as
sorbitol esters with oleic, myristic, stearic, palmitic acid also known as those known
under the tradenames Tweens® from ICI or Glycosperse® from LONZA), sucrose
esters with C8-C20 fatty acid (such as sucrose esters with oleic, palmitic or stearic acid,
such as Ryoto Sugar Ester M-1695 commercialized by Mitsubishi-Kagaku Foods
Corporation), ethoxylated aliphatic C6-C20 alcohols containing 2 to 30 EO units (such
as ethoxylated secondary C 6-C20 alcohols), C8-C20 polyglyceryl esters (such as
glycerol-polyethylene glycol oxystearate commercialized by BASF under the trade
name Chromophor® CO40), polyethylene glycol and polypropylene glycol block
copolymers (such as those known under the tradename Pluronics® from BASF),
ethoxylated glycol ether containing 2 to 30 EO units (such as PEG-10 stearyl ether also
known under the trade name Volpo® S-10 from CRODA), or polyethylene glycol
mono-or-diester of aliphatic C5-C11 carboxylic acids containing 2 to 10 EO units (EO
stands for ethylene oxide and PO stands for propylene oxide) and mixtures thereof. (C8
- CI4) Alkyl glucoside such as decylglucoside, polysorbates, caprylyl/caprylglucoside
and mixtures thereof are the preferred non-ionic surfactant.
Amphoteric surfactants suitable for use in the present invention can be selected from but
are not limited to derivatives of aliphatic secondary and tertiary amines in which the
aliphatic radical can be straight chain or branched and wherein one of the aliphatic
substituents contains from about 8 to about 18 carbon atoms and one contains an anionic
water solubilizing group, e.g., carboxy, sulfonate, sulfate, phosphate, or phosphonate.
Compounds falling within this definition include sodium 3-dodecylaminopropionate,
sodium 3-dodecylaminopropane sulfonate; N-alkyltaurines, N-higher alkyl aspartic
acids. Other amphoterics such as betaines are also useful in the present composition.
Examples of betaines useful herein include the high alkyl betaines such as coco
dimethyl carboxymethyl betaine, lauryl dimethyl carboxy-methyl betaine, lauryl

dimethyl alpha-carboxyethyl betaine, cetyl dimethyl carboxymethyl betaine, lauryl bis-
(2-hydroxyethyl)carboxy methyl betaine, stearyl bis-(2-hydroxypropyl)carboxymethyl
betaine, oleyl dimethyl gamma-carboxypropyl betaine, lauryl bis-(2-hydro-
xypropyl)alpha-carboxyet-hyl betaine, coco dimethyl carboxymethyl betaine, lauryl
dimethyl carboxymethyl betaine, and stearyl bis-(2-hydroxypropyl) carboxymethyl
betaine, and sodium lauryl diethylene diamnioglycinate), sultaines (e.g. cocamidopropyl
hydroxysultaine and sodium lauroyl sarcosinate), and mixtures thereof.Lauryl betaine,
cocoamidobetaines, oleyl betaine, caprylamidopropyl betaine, isostearylamidopropyl
betaine, coco imidoazolinium betaine Cocamidopropyl betaine CAPB, succinate,
cocobetaine, lauroamidopropyl betaines and mixtures thereof are the preferred
amphoteric surfactants. The amphoteric surfactant is present in a range of about 1-20
wt% preferably from 2 to 15%.
Another embodiment of the present invention provides a process for the preparation of
the foaming non-soap based cleansing composition with high amount of
FFAcomprising steps of
a) Weighing the surfactants in a container and keeping it aside for continuous
stirring at a temperature ranging from 50-70°C for about 5 to 60 minutes. The
continuous stirring process helps in the formation of phase A.
b) Preparing phase B by melting fatty acids in a container kept in a water bath at a
temperature ranging from 50 to 80 C for about 5 to 60 minutes under continuous
stirring.
c) Weighing and mixing polymers and water soluble actives Which is helpful for
thepreparation of phase C.
d) Adding and mixing phase A and phase C together to form a homogenous
mixture.
e) Adding phase B to the homogenous mixture of step (d) and stirring continuously
to obtain the desired formulation of the present invention.
The criticality lies in the temperature of addition of the phases and the ratio of
components used in order to achieve desired formulation.

The fatty acids are essential for the foaming non-soap based skin cleansing composition
of the present invention and also their combination in a particular ratio and range is
important to achieve the desired result. Myristic acid is used in the range of 15 to 30%
w/w, Palmitic acid is used in the range of 15 to 35% w/w, Stearic acid is used in the
range of 15 to 35% w/w and Laurie acid is used in the range of 15 to 35% w/w.
The surfactant mixture is around 1-20 % w/w in the sample comprises anionic, non
ionic and amphoteric surfactant.
Phase A as mentioned above comprises of mixture of surfactants chosen from anionic,
nonionic and amphoteric surfactant.
Phase B as mentioned in the second process step comprises of mixture of fatty acids
chosen from C10 to C20, most preferably C12 to C18 alkyl chain length such as lauric acid,
myristic acid, palmitic acid, stearic acid.
Phase C mentioned in the third step of the process disclosed above comprises of
polymers of natural or synesthetic origin or mixture thereof and water soluble benefit
ingredients such as humectants (glycerin, sorbitol or their mixture), amino acids and
their derivatives, moisturizers such as sodium hyaluronate, conditioning agents such as
panthenol, vitamins such as ascorbic acid or its derivatives, tocopherol or its derivatives,
skin lightening agents such as arbutin, skin exfoliating agents such as salicylic acid,
glycolic acid.
The following examples further describe and demonstrate the embodiments of the
present invention. The examples provided are solely for illustration and should not be
construed as limitations of the invention.
Example 1
Table 1 list out the free fatty acids and suitable working ratio essential to impart creamy
viscous liquid texture to the composition.


Process involved:
a) Weighing the surfactants in a container and keeping it aside for continuous
gentle stirring at a temperature ranging from 50-70°C for about 5 to 60 minutes.
The continuous stirring process helps in the formation of phase A.
b) Preparing phase B by melting fatty acids in a water bath at a temperature ranging
from 50 to 80°C for about 5 to 60 minutes.
c) Adding phase B to the phase A and stirring continuously to obtain the desired
formulation of the present invention.
Evaluation:
Following the above process different sets of compositions were prepared by weighing
surfactants and fatty acids in a specified ratio astabulated inworking and non-working

examples given below and evaluated in terms of their percentage reduction in foam
volume.
The results indicated the significance of the combination of surfactant mixtures and
fatty acid components in specified ratiosfor achieving the desired result by using the
said cleansing composition


Process:
a) Weighing the surfactants (Sodium lauryl sarcocinate (SoLSa), Sodium Methyl
Cocoyl Taurate and Decyl Glucoside) in a container and keeping it aside for

continuous stirring at a temperature ranging from 50-70°C for about 5 to 60
minutes. The continuous stirring process helps in the formation of phase A.
b) Preparing phase B by melting fatty acids (Myristic acid, Palmitic acid, Stearic
acid and Laurie acid) in a water bath at a temperature ranging from 50 to 80°C
for about 5 to 60 minutes.
c) Weighing and mixing Glycerin, Cetearylpolyglucoside, Sodium hyaluronate,
Xanthan Gum, Disodium EDTA , BHT and water for the preparation of phase
C.
d) Adding and mixing phase A and phase C together to form a homogenous
mixture.
e) Adding phase B to the homogenous mixture of step (d) and stirring continuously
and add fragrance to obtain the desired formulation of the present invention.
Result and Observation: A viscous creamy liquid, stable on storage, was obtained that
showed minimum reduction of foam volume even after addition of FFA

Process:
a) Weighing the surfactants (Sodium lauryl sarcocinate (SoLSa), Sodium Methyl
Cocoyl Taurate and Decyl Glucoside) in a container and keeping it aside for
continuous stirring at a temperature ranging from 50-70°C for about 5 to 60
minutes. The continuous stirring process helps in the formation of phase A.
b) Preparing phase B by melting fatty acids (Myristic acid, Palmitic acid, Stearic
acid and Laurie acid) in a water bath at a temperature ranging from 50 to 80°C
for about 5 to 60 minutes.
c) Weighing and mixing Glycerin, Cetearylpolyglucoside, Sodium hyaluronate,
Xanthan Gum , Disodium EDTA , BHT and water for the preparation of phase
C.
d) Adding and mixing phase A and phase C together to form a homogenous
mixture.
e) Adding phase B to the homogenous mixture of step (d) and stirring continuously
and add fragrance to obtain the desired formulation of the present invention.
Result and Observation: A viscous creamy liquid, stable on storage, was obtained that
showed minimum reduction of foam volume even after addition of FF A.

Process:
a) Weighing the surfactants (Sodium lauryl sarcocinate (SoLSa), Sodium Methyl
Cocoyl Taurate and Decyl Glucoside) in a container and keeping it aside for
continuous stirring at a temperature ranging from 50-70°C for about 5 to 60
minutes. The continuous stirring process helps in the formation of phase A.
b) Preparing phase B by melting fatty acids (Myristic acid, Palmitic acid, Stearic
acid and Laurie acid) in a water bath at a temperature ranging from 50 to 80 C
for about 5 to 60 minutes.
c) Weighing and mixing Glycerin, Cetearylpolyglucoside, Sodium hyaluronate,
Xanthan Gum , Disodium EDTA , BHT and water for the preparation of phase
C.
d) Adding and mixing phase A and phase C together to form a homogenous
mixture.
e) Adding phase B to the homogenous mixture of step (d) and stirring continuously
and add fragrance to obtain the desired formulation of the present invention.
Result and Observation: A free flowing liquid, phase separate on storage, was
obtained that showed unacceptably higher drop in foam volume after addition of FFA
Example 5: Non working (negative) example



Process:
a) Weighing the surfactants (Sodium lauryl sarcocinate (SoLSa), Sodium Methyl
Cocoyl Taurate and Decyl Glucoside) in a container and keeping it aside for
continuous stirring at a temperature ranging from 50-70°C for about 5 to 60
minutes. The continuous stirring process helps in the formation of phase A.
b) Preparing phase B by melting fatty acids (Myristic acid, Palmitic acid, Stearic
acid and Laurie acid) in a water bath at a temperature ranging from 50 to 80°C
for about 5 to 60 minutes.

c) Weighing and mixing Glycerin, Cetearylpolyglucoside, Sodium hyaluronate,
Xanthan Gum , Disodium EDTA , BHT and water for the preparation of phase
C.
d) Adding and mixing phase A and phase C together to form a homogenous
mixture.
e) Adding phase B to the homogenous mixture of step (d) and stirring continuously
and add fragrance to obtain the desired formulation of the present invention.
Result and Observation: A free flowing liquid, phase separate on storage, was
obtained that showed unacceptably higher drop in foam volume after addition of FFA
Example 6: The negative example in which desired result is not achieved if the fatty
acids are not combined in the above mentioned ranges.


Process involved:
a) Weighing the surfactants in a container and keeping it aside for continuous
stirring at a temperature ranging from 50-70°C for about 5 to 60 minutes. The
continuous stirring process helps in the formation of phase A.
b) Preparing phase B by melting fatty acids in a water bath at a temperature ranging
from 50 to 80°C for about 5 to 60 minutes.
c) Adding phase B to the phase A and stirring continuously to obtain the desired
formulation of the present invention.
Result and observation: the creamy texture of the non-soap based foaming cleansing
composition is not achieved and instead a viscous liquid is obtained. It was observed
that this is because the unique combination of the fatty acids, and fatty acids and
surfactants was not maintained.
Example 7: The negative example in which desired result is not achieved if the fatty
acids are not combined in the above mentioned ranges.


Process involved:
a. Weighing the surfactants in a container and keeping it aside for continuous
stirring at a temperature ranging from 50-70°C for about 5 to 60 minutes. The
continuous stirring process helps in the formation of phase A.
b. Preparing phase B by melting fatty acids in a water bath at a temperature ranging
from 50 to 80°C for about 5 to 60 minutes under continuous stirring.
c. Adding phase B to the phase A and stirring continuously to obtain the desired
formulation of the present invention.
Result and observation: the creamy texture of the non-soap based foaming cleansing
composition is not achieved and instead a free flowing liquid is obtained. It was

observed that this is because the unique combination of the fatty acids, and fatty acids
and surfactants was not maintained.

WE CLAIM:
1. A foaming non-soap based skincleansing composition comprising
a) 0.1 to 10% w/w free fatty acids;
b) 2 to 30% w/wsurfactants;and
c) water;
wherein said free fatty acids are combination of C10 to C20 fatty acids selected
from the group comprising Lauric acid, Myristic acid, Palmitic acid, and Stearic
acid, and
wherein said free fatty acids and surfactants are combined in the ratio of 1: 20
to 1:3
such that the destruction of foam by the presence of fatty acids is prevented.
2. The foaming non-soap based skin care composition as claimed in claim 1,
wherein surfactant is an anionic surfactant selected from a group comprising
Sodium lauryl sarcocinate, Sodium Methyl Cocoyl Taurate, glutamate such as
disodiumcocoyl glutamate, sulfosuccinate, isethionate and mixtures thereof.
3. The foaming non-soap based skin care composition as claimed in claim 1,
wherein surfactant is a nonionic surfactant selected from a group comprising
(C8-C14) Alkyl glucosides such as Decyl Glucoside, polysorbates,
Caprylyl/Capryl Glucoside and mixtures thereof.
4. The foaming non-soap based skin cleansing composition as claimed in claim 1,
wherein the surfactant is an amphoteric surfactant selected from aliphatic
secondary and tertiary amines and preferably from the group comprising of
Lauryl betaine, cocoamidobetaines, oleylbetaine, caprylamidopropyl betaine,
isostearylamidopropyl betaine, coco imidoazolinium betaine Cocamidopropyl
betaine CAPB, succinate, cocobetaine, lauroamidopropyl betaines and mixtures
thereof.

5. The foaming non-soap skin cleansing composition as claimed in claim 1,
wherein free fatty acids can be selected from a group comprising Laurie
acids,Myristic, Palmitic, and Stearic .
6. The foaming non-soap skin care composition as claimed in claim 2, wherein the
amount of anionic surfactant ranges from 1- 20 wt %.
7. The foaming non-soap skin care composition as claimed in claim 3, wherein the
amount of nonionic surfactant ranges from 1-20 wt%.
8. The foaming non-soap skin care composition as claimed in claim 4, wherein the
amount of amphoteric surfactant ranges from 1-20 wt%.
9. The foaming non-soap skin cleansing composition according to claim 1, where
in the said composition can be derived in a form of face wash, body wash,
shower gel, soap and other cleansing formulations.
10. A process for the preparation of a foaming non-soap based skin care
composition as claimed in any claims 1 to 9 comprising steps of
a. weighing the surfactants in a container and keeping it aside for continuous
stirring at a temperature ranging from 50-70°C for about 5 to60 minutesto
form phase A;
b. preparing phase B by melting fatty acids in a water bath at a temperature
ranging from 50 to 80°C for about 5 to 60 minutes;
c. weighing and mixing polymers and water soluble actives to form phase C;
d. adding and mixing phase A and phase C together to form a homogenous
mixture;

e. adding phase B to the homogenous mixture of step (d) and stirring
continuously to obtain the foaming non-soap skin care composition.
11. The process as claimed in claim 10, wherein said phase A comprises of a
mixture of surfactants chosen from anionic, nonionic and amphoteric
surfactants.
12. The process as claimed in claim 10, wherein said phase B comprises ofmixture
of fatty acids chosen from C10 to C20, most preferably C12 to C18 alkyl chain
length such as lauric acid, myristic acid, palmitic acid, stearic acid.
13. The process as claimed in claim 10, wherein said phase C comprises of polymers
of natural or synthetic origin or mixture thereof and water soluble benefit
ingredients selected from humectants (glycerin, sorbitol or their mixture), amino
acids and their derivatives, moisturizers such as sodium hyaluronate,
conditioning agents such as panthenol, vitamins such as ascorbic acid or its
derivatives, tocopherol or its derivatives, skin lightening agents such as arbutin,
skin exfoliating agents such as salicylic acid, glycolic acid.

ABSTRACT

A foaming non-soap based skin cleansing composition comprising0.l to 10% w/w free
fatty acids; 2 to 30% w/w surfactants; and water; wherein said free fatty acids are
combination of C10 to C20 fatty acids selected from the group comprising Lauric acid,
Myristic acid, Palmitic acid, and Stearic acid, and wherein said free fatty acids and
surfactants are combined in the ratio of 1: 20 to 1:3; such that the destruction of foam by
the presence of fatty acids is prevented.Also provided isa process for the preparation of
the foaming non-soap skin care composition.

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 1153-KOL-2013-(07-10-2013)SPECIFICATION.pdf 2013-10-07
1 1153-KOL-2013-RELEVANT DOCUMENTS [30-09-2023(online)].pdf 2023-09-30
2 1153-KOL-2013-(07-10-2013)FORM-3.pdf 2013-10-07
2 1153-KOL-2013-RELEVANT DOCUMENTS [27-09-2022(online)].pdf 2022-09-27
3 1153-KOL-2013-RELEVANT DOCUMENTS [25-09-2021(online)].pdf 2021-09-25
3 1153-KOL-2013-(07-10-2013)FORM-2.pdf 2013-10-07
4 1153-KOL-2013-RELEVANT DOCUMENTS [25-03-2020(online)].pdf 2020-03-25
4 1153-KOL-2013-(07-10-2013)FORM-1.pdf 2013-10-07
5 1153-KOL-2013-IntimationOfGrant02-09-2019.pdf 2019-09-02
5 1153-KOL-2013-(07-10-2013)DESCRIPTION (COMPLETE).pdf 2013-10-07
6 1153-KOL-2013-PatentCertificate02-09-2019.pdf 2019-09-02
6 1153-KOL-2013-(07-10-2013)CORRESPONDENCE.pdf 2013-10-07
7 1153-KOL-2013-Response to office action (Mandatory) [27-08-2019(online)].pdf 2019-08-27
7 1153-KOL-2013-(07-10-2013)CLAIMS.pdf 2013-10-07
8 1153-KOL-2013-Written submissions and relevant documents (MANDATORY) [26-04-2019(online)].pdf 2019-04-26
8 1153-KOL-2013-(07-10-2013)ABSTRACT.pdf 2013-10-07
9 1153-KOL-2013-(06-11-2013)-FORM-1.pdf 2013-11-06
9 1153-KOL-2013-HearingNoticeLetter.pdf 2019-03-04
10 1153-KOL-2013-CLAIMS [25-07-2018(online)].pdf 2018-07-25
10 1153-KOL-2013-FORM-18.pdf 2014-01-02
11 1153-KOL-2013-FER.pdf 2017-10-26
11 1153-KOL-2013-FER_SER_REPLY [25-07-2018(online)].pdf 2018-07-25
12 1153-KOL-2013-FORM 4(ii) [26-04-2018(online)].pdf 2018-04-26
12 1153-KOL-2013-OTHERS [25-07-2018(online)].pdf 2018-07-25
13 1153-KOL-2013-FORM 4(ii) [26-04-2018(online)].pdf 2018-04-26
13 1153-KOL-2013-OTHERS [25-07-2018(online)].pdf 2018-07-25
14 1153-KOL-2013-FER.pdf 2017-10-26
14 1153-KOL-2013-FER_SER_REPLY [25-07-2018(online)].pdf 2018-07-25
15 1153-KOL-2013-CLAIMS [25-07-2018(online)].pdf 2018-07-25
15 1153-KOL-2013-FORM-18.pdf 2014-01-02
16 1153-KOL-2013-(06-11-2013)-FORM-1.pdf 2013-11-06
16 1153-KOL-2013-HearingNoticeLetter.pdf 2019-03-04
17 1153-KOL-2013-Written submissions and relevant documents (MANDATORY) [26-04-2019(online)].pdf 2019-04-26
17 1153-KOL-2013-(07-10-2013)ABSTRACT.pdf 2013-10-07
18 1153-KOL-2013-Response to office action (Mandatory) [27-08-2019(online)].pdf 2019-08-27
18 1153-KOL-2013-(07-10-2013)CLAIMS.pdf 2013-10-07
19 1153-KOL-2013-PatentCertificate02-09-2019.pdf 2019-09-02
19 1153-KOL-2013-(07-10-2013)CORRESPONDENCE.pdf 2013-10-07
20 1153-KOL-2013-IntimationOfGrant02-09-2019.pdf 2019-09-02
20 1153-KOL-2013-(07-10-2013)DESCRIPTION (COMPLETE).pdf 2013-10-07
21 1153-KOL-2013-RELEVANT DOCUMENTS [25-03-2020(online)].pdf 2020-03-25
21 1153-KOL-2013-(07-10-2013)FORM-1.pdf 2013-10-07
22 1153-KOL-2013-RELEVANT DOCUMENTS [25-09-2021(online)].pdf 2021-09-25
22 1153-KOL-2013-(07-10-2013)FORM-2.pdf 2013-10-07
23 1153-KOL-2013-RELEVANT DOCUMENTS [27-09-2022(online)].pdf 2022-09-27
23 1153-KOL-2013-(07-10-2013)FORM-3.pdf 2013-10-07
24 1153-KOL-2013-RELEVANT DOCUMENTS [30-09-2023(online)].pdf 2023-09-30
24 1153-KOL-2013-(07-10-2013)SPECIFICATION.pdf 2013-10-07

Search Strategy

1 SearchStrategy1153_26-10-2017.pdf

ERegister / Renewals

3rd: 22 Oct 2019

From 07/10/2015 - To 07/10/2016

4th: 22 Oct 2019

From 07/10/2016 - To 07/10/2017

5th: 22 Oct 2019

From 07/10/2017 - To 07/10/2018

6th: 22 Oct 2019

From 07/10/2018 - To 07/10/2019

7th: 22 Oct 2019

From 07/10/2019 - To 07/10/2020

8th: 31 Oct 2019

From 07/10/2020 - To 07/10/2021

9th: 18 Mar 2021

From 07/10/2021 - To 07/10/2022

10th: 16 Dec 2021

From 07/10/2022 - To 07/10/2023

11th: 25 Nov 2022

From 07/10/2023 - To 07/10/2024

12th: 04 Oct 2024

From 07/10/2024 - To 07/10/2025

13th: 02 Jan 2025

From 07/10/2025 - To 07/10/2026

14th: 02 Jan 2025

From 07/10/2026 - To 07/10/2027

15th: 02 Jan 2025

From 07/10/2027 - To 07/10/2028

16th: 02 Jan 2025

From 07/10/2028 - To 07/10/2029

17th: 02 Jan 2025

From 07/10/2029 - To 07/10/2030

18th: 02 Jan 2025

From 07/10/2030 - To 07/10/2031

19th: 02 Jan 2025

From 07/10/2031 - To 07/10/2032

20th: 02 Jan 2025

From 07/10/2032 - To 07/10/2033